Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells.
Abstract
Cisplatin [cis-dichlorodiammine platinum (II), CDDP], morphine (Mor), and electromagnetic field (EMF) induced oxidative stress. In this study, we tried to increase the cytotoxicity of CDDP in combination with Mor and/or EMF in MCF-7 and SH-SY5Y cells. Furthermore, we evaluate the expression levels of 11 antioxidant genes in both cell lines. We designed four treatments: CDDP alone, "CDDP+Mor," "CDDP+EMF," and "CDDP+Mor+EMF." Serial dilutions of CDDP, Mor (5.0 μM), and EMF (50 Hz, 0.50 mT, "15 min field-on/15 min field-off") were used for estimation of relative IC values. The mRNA expression levels of antioxidant genes were determined by real-time PCR. The IC value of CDDP in "CDDP+Mor+EMF" treatment was significantly higher than CDDP alone and "CDDP+Mor" treatments in both cell lines. Whereas the expression levels of antioxidant genes in the four treatments showed similar patterns in MCF-7 cells, in SH-SY5Y cells, most of the antioxidant genes showed an upregulation with "CDDP+EMF" and "CDDP+Mor+EMF" treatments. Moreover, significant differences in the number of upregulated genes were observed between different treatments in SH-SY5Y cells. The molecular mechanism of CDDP-reduced cytotoxicity in our designed combinations is probably different in MCF-7 and SH-SY5Y cells. CDDP in combination with EMF could protect SH-SY5Y cells from the cytotoxicity, whereas it has no significant change in MCF-7 cells.
AI evidence extraction
Main findings
In both MCF-7 and SH-SY5Y cells, the IC value of cisplatin in the CDDP+Mor+EMF condition was significantly higher than with CDDP alone and CDDP+Mor. In SH-SY5Y cells, most antioxidant genes were upregulated with CDDP+EMF and CDDP+Mor+EMF, while MCF-7 showed similar antioxidant gene expression patterns across treatments. The authors report that EMF in combination with CDDP could protect SH-SY5Y cells from cytotoxicity, with no significant change in MCF-7 cells.
Outcomes measured
- Cisplatin (CDDP) cytotoxicity (IC values)
- mRNA expression levels of 11 antioxidant genes (real-time PCR)
Limitations
- In vitro study (cell lines), not directly generalizable to humans
- Sample size/replicates not reported in abstract
- Exposure details limited to 50 Hz, 0.50 mT and duty cycle; total exposure duration not specified
- Only antioxidant gene mRNA expression assessed (no protein/activity measures described in abstract)
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": "ELF",
"source": "other",
"frequency_mhz": null,
"sar_wkg": null,
"duration": "15 min field-on/15 min field-off"
},
"population": "MCF-7 and SH-SY5Y cell lines",
"sample_size": null,
"outcomes": [
"Cisplatin (CDDP) cytotoxicity (IC values)",
"mRNA expression levels of 11 antioxidant genes (real-time PCR)"
],
"main_findings": "In both MCF-7 and SH-SY5Y cells, the IC value of cisplatin in the CDDP+Mor+EMF condition was significantly higher than with CDDP alone and CDDP+Mor. In SH-SY5Y cells, most antioxidant genes were upregulated with CDDP+EMF and CDDP+Mor+EMF, while MCF-7 showed similar antioxidant gene expression patterns across treatments. The authors report that EMF in combination with CDDP could protect SH-SY5Y cells from cytotoxicity, with no significant change in MCF-7 cells.",
"effect_direction": "mixed",
"limitations": [
"In vitro study (cell lines), not directly generalizable to humans",
"Sample size/replicates not reported in abstract",
"Exposure details limited to 50 Hz, 0.50 mT and duty cycle; total exposure duration not specified",
"Only antioxidant gene mRNA expression assessed (no protein/activity measures described in abstract)"
],
"evidence_strength": "very_low",
"confidence": 0.7800000000000000266453525910037569701671600341796875,
"peer_reviewed_likely": "yes",
"keywords": [
"ELF-EMF",
"50 Hz",
"0.50 mT",
"cisplatin",
"morphine",
"MCF-7",
"SH-SY5Y",
"oxidative stress",
"antioxidant genes",
"cytotoxicity",
"IC value"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.